Abacavir, dolutegravir, and lamivudine and Telavancin Hydrochloride

• Generic Name: abacavir / dolutegravir / lamivudine
• Dosage Forms: n.a.
• Other Brand Names: Triumeq

Abacavir, dolutegravir, and lamivudine (Triumeq) is a combination medicine used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). abacavir, dolutegravir, and lamivudine is not a cure for HIV or AIDS.

Triumeq is for use in adults and children who weigh at least 88 pounds (40 kilograms).

Triumeq may also be used for purposes not listed in this medication guide.

• Generic Name: telavancin
• Dosage Forms: n.a.
• Other Brand Names: Vibativ

Treatment of nosocomial pneumonia, including hospital-acquired and ventilator-associated pneumonia, caused by susceptible Staphylococcus aureus (including methicillin-resistant S. aureus [MRSA; also known as oxacillin-resistant S. aureus or ORSA]).

If documented or presumed pathogens also include gram-negative or anaerobic bacteria, concomitant use of an anti-infective active against such bacteria may be clinically indicated.

Manufacturer states reserve telavancin for use when alternative treatments for hospital-acquired or ventilator-associated bacterial pneumonia not suitable.

Skin and Skin Structure Infections

Treatment of complicated skin and skin structure infections caused by susceptible S. aureus (including MRSA), Streptococcus pyogenes (group A β-hemolytic streptococci, GAS), S. agalactiae (group B streptococci, GBS), S. anginosus group (includes S. anginosus, S. intermedius, S. constellatus), or Enterococcus faecalis (vancomycin-susceptible strains only).

If documented or presumed pathogens also include gram-negative or anaerobic bacteria, concomitant use of an anti-infective active against such bacteria may be clinically indicated.